Diptheria Pertussis Tetanus (dpt)vaccine

Diptheria Pertussis Tetanus (dpt)vaccine

Form: Injection

Strength: Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units

Reference Brands: Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU)

Category: Hepatitis

The Diphtheria, Pertussis, Tetanus (DPT) vaccine injection is a combined immunization product providing protection against three serious bacterial diseases. It contains standardized doses of diphtheria toxoid (≥30 IU), tetanus toxoid (≥40 IU), and whole-cell or acellular pertussis antigens per 0.5 mL dose. Administered intramuscularly, it is essential in pediatric vaccination schedules to prevent diphtheria, whooping cough, and tetanus. Manufactured under stringent EU-GMP and USFDA standards, the DPT vaccine is widely supplied for hospital tenders, public health programs, and B2B distribution in the EU and US markets, supporting immunization coverage worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details Get Enquiry
Glecaprevir/Pibrentasvir

Strength: Glecaprevir 100 mg Pibrentasvir 40 mg

Form: Oral tablets

Reference Brands: Mavyret®,

View Details Get Enquiry
Ribavirin

Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

View Details Get Enquiry
Adefovir Dipivoxil

Strength: 10 mg

Form: Oral tablets

Reference Brands: Hepsera® (EU & US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.